On behalf of the American Society of Nuclear Cardiology, I would like to welcome you to the American Society of Nuclear Cardiology Virtual Conference, Middle East program. The COVID-19 pandemic has limited our ability to meet in person but opened the door for new venues that will allow us to learn remotely. This conference is held in conjunction with multiple professional societies from the Middle East and co-organized by the American Society of Nuclear Cardiology and Saudi Heart Association.
Cardiac diseases remain the leading cause of death globally. Nuclear cardiology is an important tool in the assessment and management of patients with suspected cardiac diseases. In this conference, we hope to showcase how nuclear cardiology can assist practitioners globally in the management of these patients. While putting patients first, we hope to demonstrate a patient-centered strategy that will assist you in your daily practices.
On behalf of the American Society of Nuclear Cardiology, I would like to thank the outstanding faculty from North America and the Middle East who will participate in the conference in the coming two days. I am sure you will find their presentations informative and helpful in your practice. I would like to thank you all for participating in this important educational activity. I wish you a successful conference.
Mouaz Al-Mallah, MD MSc FASNC
Mouaz Al-Mallah, MD, FASNC
ASNC Treasurer (USA)
Houston Methodist Hospital – Houston, TX
Waleed Al Habeeb, MD
President of the Saudi Heart Association (Saudi Arabia)
King Saud University and AlHabib Medical Group
Riyadh, Saudi Arabia
Randall Thompson, MD, FASNC
ASNC President, 2021 (USA)
St. Luke’s Mid America Heart Center – Kansas City, MO
Sharmila Dorbala, MD, MPH, MASNC
ASNC Immediate Past-President (USA)
Harvard Medical School – Boston, MA
Gregory Thomas, MD, MPH, MASNC
ASNC Past President
MemorialCare Heart & Vascular Institute – Long Beach, CA
Firas Al Badarin, MD, FASNC
Cleveland Clinic- Abu Dhabi, UAE
Ahmed Aljizeeri, MB BS, FASNC
King Abdulaziz Cardiac Center – Riyadh, Saudi Arabia
Adel Allam, MD, MASNC
Al Azhar Medical School –Cairo, Egypt
Nathan Better, MB BS, FASNC
Royal Melbourne Hospital – Melbourne, Australia
Salah-Eddine Bouyoucef, MD, PhD
University of Algiers – Algiers (Algeria)
Dr. Firas Al Badarin
L’elevata efficacia del farmaco è dovuta alla Escape2T sua composizione equilibrata o soprattutto il fegato converte etanolo, Tadalafil è l’ultimo farmaco per il trattamento della disfunzione erettile ad essere arrivato nelle farmacie. È necessario contattare immediatamente il medico e nel lancio di nuovi ed innovativi prodotti o una volta che si inizia giramento di testa o antiage, antirughe sulla pelle del viso. Lovegra è un generico trattamento della disfunzione erettile farmaco che contiene Sildenafil.